Evaluation of biochemical recurrence in patients with high-risk prostate cancer treated with radical prostatectomy and radiotherapy plus androgen deprivation therapy

References

• HeidenreichABellmuntJBollaMEAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localized diseaseEur Urol2011591617121056534
   PubMed Web of Science ®Google Scholar
• CooperbergMRBroeringJMCarrollPRTime trends and local variation in primary treatment of localized prostate cancerJ Clin Oncol20102871117112320124165
   PubMed Web of Science ®Google Scholar
• National Comprehensive Cancer NetworkClinical Practice Guidelines in Oncology, Prostate Cancer Fort Washington, PANCCN2015
   Google Scholar
• HeidenreichABastianPJBellmuntJEAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013Eur Urol201465112413724207135
   PubMed Web of Science ®Google Scholar
• NguyenPLChenMHCatalonaWJMoulJWSunLD’amicoAVPredicting prostate cancer mortality among men with intermediate to high-risk disease and multiple unfavorable risk factorsInt J Radiat Oncol Biol Phys200973365966418692327
   PubMed Web of Science ®Google Scholar
• ZelefskyMJEasthamJACroninAMMetastasis after radical prostatectomy or external beam radiotherapy for patients with clinically localized prostate cancer: a comparison of clinical cohorts adjusted for case mixJ Clin Oncol20102891508151320159826
   PubMed Web of Science ®Google Scholar
• CooperbergMRVickersAJBroeringJMCarrollPRComparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancerCancer2010116225226523420690197
   PubMed Web of Science ®Google Scholar
• FletcherSGMillsSESmolkinMETheodorescuDCasematched comparison of contempory radiation therapy to surgery in patients with locally advanced prostate cancerInt J Radiat Oncol Biol Phys20066641092109916965872
   PubMed Web of Science ®Google Scholar
• ArcangeliGStrigariLArcangeliSRetrospective comparison of external beam radiotherapy and radical prostatectomy in high-risk, clinically localized prostate cancerInt J Radiat Oncol Biol Phys200975497598219395188
   PubMed Web of Science ®Google Scholar
• AkakuraKSuzukiHIchikawaTA randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 monthsJpn J Clin Oncol2006361278979317082219
   PubMed Web of Science ®Google Scholar
• BoorjianSAKarnesRJViterboRLong-term survival after radical prostatectomy versus external-beam radiotherapy for patients with high-risk prostate cancerCancer2011117132883289121692049
   PubMed Web of Science ®Google Scholar
• MengMVElkinEPLatiniDMDuchaneJCarrollPRTreatment of patients with high risk localized prostate cancer: results from Cancer of the Prostate Strategic Urological Research Endeavor (CaPSURE)J Urol200517351557156115821485
   PubMed Web of Science ®Google Scholar
• KleinEACiezkiJKupelianPAMahadevanAOutcomes for intermediate risk prostate cancer: are there advantages for surgery, external radiation, or brachytherapy?Urol Oncol2009271677119111801
   PubMed Web of Science ®Google Scholar
• D’AmicoAVWhittingtonRMalkowiczSBBiochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancerJAMA1998280119699749749478
   PubMed Web of Science ®Google Scholar
• WalzJJoniauSChunFKPathological results and rates of treatment failure in high-risk prostate cancer patients after radical prostatectomyBJU Int2011107576577020875089
   PubMed Web of Science ®Google Scholar
• LoddeMHarelFLacombeLFradetYSubstratification of high-risk localized prostate cancer treated by radical prostatectomyWorld J Urol200826322522918369635
   PubMed Web of Science ®Google Scholar
• YamamotoSKawakamiSYoneseJLong-term oncological outcome and risk stratification in men with high-risk prostate cancer treated with radical prostatectomyJpn J Clin Oncol201242654154722457326
   PubMed Web of Science ®Google Scholar
• JoniauSBrigantiAGonteroPStratification of high-risk prostate cancer into prognostic categories: a European multi-institutional studyEur Urol201567115716424486307
   PubMed Web of Science ®Google Scholar
• SpahnMJoniauSGonteroPOutcome predictors of radical prostatectomy in patients with prostate-specific antigen greater than 20 ng/ml: a European multi-institutional study of 712 patientsEur Urol20105811720299147
   PubMed Web of Science ®Google Scholar
• YossepowitchOEggenerSEBiancoFJJrRadical prostatectomy for clinically localized, high risk prostate cancer: critical analysis of risk assessment methodsJ Urol2007178249349917561152
   PubMed Web of Science ®Google Scholar
• MuralidharVChenMHReznorGDefinition and validation of “favorable high-risk prostate cancer”: implications for personalizing treatment of radiation-managed patientsInt J Radiat Oncol Biol Phys201593482883526530751
   PubMed Web of Science ®Google Scholar
• HeidenreichAAusGBollaMEuropean Association of Urology. EAU guidelines on prostate cancerEur Urol2008531688017920184
   PubMed Web of Science ®Google Scholar
• RoachM3rdHanksGThamesHJrDefining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus ConferenceInt J Radiat Oncol Biol Phys200665496597416798415
   PubMed Web of Science ®Google Scholar
• BollaMvan PoppelHTombalBPostoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)Lancet201238098582018202723084481
   PubMed Web of Science ®Google Scholar
• LeeBHKibelASCiezkiJPAre biochemical recurrence outcomes similar after radical prostatectomy and radiation therapy? Analysis of prostate cancer-specific mortality by nomogram-predicted risks of biochemical recurrenceEur Urol201567220420925294696
   PubMed Web of Science ®Google Scholar
• HernandezDJNielsenMEHanMNatural history of pathologically organ-confined (pT2), Gleason score 6 or less, prostate cancer after radical prostatectomyUrology200872117217618304619
   PubMed Web of Science ®Google Scholar
• LeeWRHanksGEHanlonAIncreasing prostate-specific antigen profile following definitive radiation therapy for localized prostate cancer: clinical observationsJ Clin Oncol1997152302388996147
   PubMed Web of Science ®Google Scholar
• PoundCRPartinAWEisenbergerMAChanDWPearsonJDWalshPCNatural history of progression after PSA elevation following radical prostatectomyJAMA1999281171591159710235151
   PubMed Web of Science ®Google Scholar
• ReeseACPierorazioPMHanMPartinAWContemporary evaluation of the National Comprehensive Cancer Network prostate cancer risk classification systemUrology20128051075107922995570
   PubMed Web of Science ®Google Scholar
• NandaAChenMHRenshawAAD’AmicoAVGleason pattern 5 prostate cancer: further stratification of patients with high-risk disease and implications for future randomized trialsInt J Radiat Oncol Biol Phys20097451419142319131185
   PubMed Web of Science ®Google Scholar